As of June 30, 2026, Molina Healthcare, Inc. carries a market capitalization of 10.34B, placing it among publicly traded companies globally. Its enterprise value stands at 6.00B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 10.34B |
| Enterprise Value | 6.00B |
Molina Healthcare, Inc.'s next confirmed earnings release is scheduled for February 10, 2027.
| Earnings Date | 2/10/2027 |
As of June 30, 2026, Molina Healthcare, Inc. has 52.00M shares outstanding.
| Shares Outstanding | 52.00M |
These figures are as of June 30, 2026. The price-to-sales ratio is 0.26, and the price-to-book ratio stands at 2.83.
| PS Ratio | 0.26 |
| PB Ratio | 2.83 |
| P/TBV Ratio | 5.66 |
| P/FCF Ratio | 43.23 |
| P/OCF Ratio | 32.05 |
As of June 30, 2026, Molina Healthcare, Inc. trades at an EV/EBITDA multiple of 18.48 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.15 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 33.76 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 6.00B versus a market cap of 10.34B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 0.15 |
| EV / EBITDA | 18.48 |
| EV / EBIT | 33.76 |
As of June 30, 2026, Molina Healthcare, Inc. maintains a current ratio of 1.68, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 94.77, indicating elevated leverage, while an interest coverage ratio of 1.78 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.68 |
| Quick Ratio | 1.61 |
| Debt / Equity | 94.77 |
| Debt / EBITDA | 10.65 |
| Interest Coverage | 1.78 |
Over the twelve months ended June 30, 2026, Molina Healthcare, Inc. posted a negative return on equity (ROE) of -0.16, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -0.04, reflecting losses generated across the asset base. The company generates approximately 2.08M in revenue per employee across its workforce of 18,750.00, a quick read on workforce productivity versus industry peers.
| Return on Equity (ROE) | -0.16 |
| Return on Assets (ROA) | -0.04 |
| Revenue Per Employee | 2.08M |
| Employee Count | 18,750.00 |
Over the twelve months ended June 30, 2026, Molina Healthcare, Inc. recorded 875,300.00 in income tax expense. The company reported a pretax loss of -5.25M and -6.13M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 875,300.00 |
As of the close on October 22, 2026, Molina Healthcare, Inc.'s stock has gained approximately 15.34% over the past 52 weeks. The 50-day moving average sits at 175.01, while the 200-day moving average is 159.32.
| 52-Week Price Change | 15.34% |
| 50-Day Moving Average | 175.01 |
| 200-Day Moving Average | 159.32 |
Over the twelve months ended June 30, 2026, Molina Healthcare, Inc. generated 38.97B in revenue and converted that into -6.13M in net income, yielding earnings per share of -0.12. EBITDA reached 324.74M, while operating income came in at 259.09M.
| Revenue | 38.97B |
| Gross Profit | 3.13B |
| Operating Income | 259.09M |
| Pretax Income | -5.25M |
| Net Income | -6.13M |
| EBITDA | 324.74M |
| EBIT | 177.69M |
| Earnings Per Share (EPS) | -0.12 |
As of June 30, 2026, Molina Healthcare, Inc. holds 7.80B in cash and equivalents against 3.46B in total debt, resulting in a net debt position of -1.06B. Total book value stands at 3.65B, with working capital of 4.58B providing operational flexibility.
| Cash & Cash Equivalents | 7.80B |
| Total Debt | 3.46B |
| Net Debt | -1.06B |
| Equity (Book Value) | 3.65B |
| Book Value Per Share | 70.21 |
| Working Capital | 4.58B |
Molina Healthcare, Inc. produced 319.48M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -82.28M in capital expenditures, free cash flow totaled 237.21M - equivalent to 4.61 per share.
| Operating Cash Flow | 319.48M |
| Capital Expenditures | -82.28M |
| Free Cash Flow | 237.21M |
| FCF Per Share | 4.61 |
Over the twelve months ended June 30, 2026, Molina Healthcare, Inc. posted a gross margin of 8.04, reflecting its pricing power and cost economics. The operating margin of 0.66 and net profit margin of -0.02 provide insight into operational efficiency.
| Gross Margin | 8.04 |
| Operating Margin | 0.66 |
| Pretax Margin | -0.01 |
| Profit Margin | -0.02 |
| EBITDA Margin | 0.83 |
These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 2.31, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 1.29, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Molina Healthcare, Inc. shareholders.
| Shareholder Yield | 1.29 |
| FCF Yield | 2.31 |
Molina Healthcare, Inc.'s most recent stock split took place on May 23, 2011 with a 2:3 split ratio.
| Last Split Date | 5/23/2011 |
| Split Ratio | 2:3 |
As of June 30, 2026, Molina Healthcare, Inc. has an Altman Z-Score of 4.69, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.69 |